menu
    • menu

    Company profile for Bio-Thera Solutions

    NEW Drugs in Dev: 38
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bio-Thera Solutions is a clinical-stage pharmaceutical company focused on biologic therapeutics. Bio-Thera is developing a pipeline on innovative enhanced monoclonal antibodies and antibody-drug conjugates for the treatment of a broad range of cancers and other diseases as well as a pipeline of biosimilars in the autoimmune and oncology therapeutic areas. The company is headquartered in Guangzhou, China.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bio-Thera SolutionsChina Flag
    Country
    Country
    China
    Address
    Address
    Bldg A6-5fl, 11Kai-Yuan Blvd, Science City, Guangzhou
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bio-thera.com/EN/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bio-thera-solutions-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Asia Pharma Expo

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    STADA and Bio-Thera Secure EU Approval for Gotenfia
    STADA and Bio-Thera Secure EU Approval for Gotenfia

    14 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/stada-and-bio-thera-receive-european-marketing-authorization-for-gotenfia-a-biosimilar-to-simponi-302687571.html

    PR NEWSWIRE
    14 Feb 2026
    Share Share
    STADA & Bio-Thera's Gotenfia Biosimilar Get Positive CHMP Opinion
    STADA & Bio-Thera's Gotenfia Biosimilar Get Positive CHMP Opinion

    12 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/golimumab-biosimilar-gotenfia-from-stada-and-bio-thera-receives-positive-chmp-opinion-302640091.html

    PR NEWSWIRE BIO
    12 Dec 2025
    Share Share
    Bio-Thera Announces Expansion of Partnership with Intas Pharma
    Bio-Thera Announces Expansion of Partnership with Intas Pharma

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-thera-solutions-announces-expansion-of-partnership-with-intas-pharmaceuticals-for-bat2506-a-proposed-biosimilar-referencing-simponi-golimumab-through-exclusive-commercialization-and-license-agreement-in-canada-302579683.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    Bio-Thera's Biosimilar Referencing Stelara Approved in the EU
    Bio-Thera's Biosimilar Referencing Stelara Approved in the EU

    26 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/bio-theras-biosimilar-referencing-stelara-approved-in-the-eu/

    CONTRACTPHARMA
    26 Aug 2025
    Share Share
    Bio-Thera, STADA Expand Biosimilars Alliance to Tocilizumab
    Bio-Thera, STADA Expand Biosimilars Alliance to Tocilizumab

    23 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-thera-and-stada-extend-biosimilars-alliance-to-tocilizumab-302536458.html

    PR NEWSWIRE
    23 Aug 2025
    Share Share
    FDA Accepts Bio-Thera's BAT2506 Biosimilar License Application
    FDA Accepts Bio-Thera's BAT2506 Biosimilar License Application

    16 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bio-thera-solutions-announces-fda-accepts-biologics-license-application-for-bat2506-a-proposed-biosimilar-to-simponi-302506633.html

    PR NEWSWIRE
    16 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search